Study Summary: This study looks at how well and safe the drug KarXT works for people with Bipolar-I Disorder experiencing manic episodes. Bipolar-I Disorder is a mental health condition with extreme mood swings, including mania, which is a period of feeling very excited or irritable.
The study lasts up to seven weeks and includes different parts like screening and a three-week stay in a hospital where patients get either KarXT or a placebo (a pill with no active medicine) without knowing which they received. This is called a "double-blind" study.
Key Points:
- The study takes up to seven weeks, including a three-week hospital stay.
- Participants must have Bipolar-I Disorder with recent manic episodes and need to stop all other psychiatric medications before starting.
- Participants cannot have certain other mental health disorders or medical conditions like severe substance use issues or risk of suicidal behavior.
How understandable was the trial content above?
Hard to understand
Easy to understand